For example, a recent report suggest that the individuals having two copies of APOE ɛ3 Christchurch (p.R136S) mutation may slow down the progression of AD by preventing the accumulation of tau tangles and associated cell death [67]. This evidence concerns the gene MAPT and Alzheimer disease.